AI tool PIONEER transforms precision medicine
Cornell Chronicle - 25-Nov-2024Transforming treatments with AI-driven insights into protein interactions and disease
Join the club for FREE to access the whole archive and other member benefits.
Transforming treatments with AI-driven insights into protein interactions and disease
These tools help surgeons plan better, reduce risks, and adapt quickly
Targeted drug delivery and immune boost for personalized cancer therapy
The system will use genetic testing to identify infections quickly
Tailored drug dosing could reduce harmful reactions for cancer patients
New funding accelerates AI advancements for precision medicine
Clinical trial shows treatment extends survival for patients with advanced lung cancer by over 40%
Breakthrough for the rarest of rare genetic diseases that affect only a few patients
Programmable mRNA tech promise precise & safe treatment for disease and age-related conditions
Fewer doses, better taste & improved adherence for rare diseases and beyond
Almost 4 million differences might be linked to disease risk, leading to targeted treatments
Project could lead to a brighter future for heart patients across Europe
This could lead to more personalised treatment plans and better outcomes
Sano's software pinpoints the perfect treatment match for each patient
Provides oncologists with a precise tumor genetic map for selecting treatments
Silicon Valley startup uses personalized data and AI twin to reverse type 2 diabetes and obesity
Company's "cell-free DNA platform" can detect unexplored cell-free DNA fragments
Government funding to fuel innovation and growth in the life science sector.
Company is transforming healthcare and enabling personalised medicine
Unlocking the secrets of cancer and genetic diseases with nanopore sequencing
CurifyLabs' pharma kit streamlines the production of tailored medications
Method can accurately predict your age, smoking status, and disease risk
Dostarlimab with 100% success rate in early trials offers hope for bowel cancer patients
Algocyte integrates data for personalised precision medicine
Lead program targets TRPV4, an ion channel that is involved in several diseases